Find a Doctor Home Clinical Trials

NYU School of Medicine - Clinical Trials
Search Cancer Clinical Trials
Title E5597: Phase III Chemoprevention trial of selenium supplementation in persons with resected stage I non small cell lung cancer 
Protocol Number E5597 
Study Contact
Name Sorensen, Audrey 
Phone 212 263 2562 
email Audrey.Sorensen@nyumc.org  
Principal Investigator
Name Pass, Harvey 
Rationale Use of selenium in preventing tumor growth in patients with previously resected Stage I Non Small Cell Lung Cancer. The primary objective is to evaluate the efficacy of selenium supplementation in reducing the incidence of second primary lung tumors in patients who have been treated for Stage I NSCLC with complete surgical resection. Patients are eligible for this study if they are post complete resection of stage IA or IB NSCLC who are currently free of disease. 
Available at: Bellevue, Clinical Cancer Center Tisch
Intervention Type Therapeutic 
Age Requirement older than 18 years
Gender males and females  
Healthy Subjects? no  
Eligibility Criteria Please refer to attached study protocol below. 
URL http://www.med.nyu.edu/nyuci/